Tenon Medical Issues Warrants to Waive Restrictions and Expand ATM Offering

Tenon Medical, Inc. has entered into a waiver agreement with an institutional investor to remove certain restrictions from a prior securities purchase agreement. This waiver permits the company to increase the size of its "at-the-market" (ATM) common stock offering. In exchange for the waiver, the company issued new warrants to the investor.

Key Details

• Agreement: On October 16, 2026, the company and an investor entered a waiver to remove restrictions from the August 27, 2026, securities purchase agreement, enabling an increase in the ATM offering.
• Consideration: Tenon issued the investor a Series B common stock purchase warrant to purchase up to 125,000 shares of common stock.
• Warrant Terms: The new warrant has an exercise price of $5.02 per share and an expiration date of September 14, 2031.
• Additional Terms: As part of the agreement, the restrictive period under the original purchase agreement was extended by 15 days to a total of 75 days. A waiver was also obtained from the placement agent, WallachBeth Capital LLC.